Last updated: 11/04/2018 02:59:06

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

GSK study ID
49653/048
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients with Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Trial description: The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
Not applicable
Allocation:
Randomized
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
  • Drug: Rosiglitazone
  • Drug: glyburide
  • Drug: metformin
  • Enrollment:
    4426
    Primary completion date:
    Not applicable
    Observational study model:
    Not applicable
    Time perspective:
    Not applicable
    Clinical publications:
    A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care, Vol 25, No. 10, October, 2002.
    A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe. Diabetic Medicine, November, 2006.
    Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. N Eng J Med: 355:2427-43, December, 2006.
    Obesity is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes. Diabetes, August, 2006
    Phenotypic Characteristics of Glutamic Acid Decarboxylase Antibody Positive, Recently Diagnosed Subjects with Type 2 Diabetes in North America and Europe. Diabetes, December, 2004.
    Kahn S, Lachin J, Zinman B, Haffner S, Aftring R, Paul G, Kravitz B, Herman W, Viberti G, Holman R. Effects of rosiglitazone, glyburide and metformin on ß-cell function and insulin sensitivity in ADOPT. Diabetes. 2011;.(Mar 17)
    Medical condition
    Diabetes Mellitus, Type 2
    Product
    rosiglitazone
    Collaborators
    Not applicable
    Study date(s)
    January 2000 to June 2006
    Type
    Interventional
    Phase
    3

    Participation criteria

    Sex
    Female & Male
    Age
    30 - 75 years
    Accepts healthy volunteers
    No
    • Newly diagnosed patients (< 3years) with type 2 diabetes.
    • Fasting plasma glucose (FPG) range of 126-240 mg/dL at Screening.
    • History of lactic acidosis.
    • Anemia (<11g for males, <10 g for females).

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Timmins, Ontario, Canada, P4N 8P2
    Status
    Study Complete
    Location
    GSK Investigational Site
    GELEEN, Netherlands, 6166 GR
    Status
    Study Complete
    Location
    GSK Investigational Site
    Crawley, Sussex West, United Kingdom, RH10 1LL
    Status
    Study Complete
    Location
    GSK Investigational Site
    Austin, Texas, United States, 78745
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Francisco, California, United States, 94143
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mataro, Spain, 08034
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Anniston, Alabama, United States, 36207
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99208
    Status
    Study Complete
    Location
    GSK Investigational Site
    HENGELO, Netherlands, 7555 DL
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lambrecht, Rheinland-Pfalz, Germany, 67466
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muenchen, Bayern, Germany, 80937
    Status
    Study Complete
    Location
    GSK Investigational Site
    St Martin D'Heres, France, 38400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Melbourn, Florida, United States, 32935
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vienna, Austria, A-1130
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kent, United Kingdom, TN11 9HL
    Status
    Study Complete
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90059
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sainte-Foy, Québec, Canada, G1V 4G5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T6G 2C8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Roelofarendsveen, Netherlands, 2371 RB
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 13355
    Status
    Recruiting
    Location
    GSK Investigational Site
    Corpus Christi, Texas, United States, 78412
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pontevedra, Spain, 36071
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M5C 2T2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fleetwood, Pennsylvania, United States, 19522
    Status
    Study Complete
    Location
    GSK Investigational Site
    EVREUX, France, 27000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Seattle, Washington, United States, 98108
    Status
    Study Complete
    Location
    GSK Investigational Site
    Malaga, Spain, 29009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75230
    Status
    Study Complete
    Location
    GSK Investigational Site
    Upland, Pennsylvania, United States, 19013
    Status
    Study Complete
    Location
    GSK Investigational Site
    Feasterville, Pennsylvania, United States, 19053
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ogden, Utah, United States, 84403
    Status
    Study Complete
    Location
    GSK Investigational Site
    Leuven, Belgium, 3000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Royal Oak, Michigan, United States, 48073
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cartagena, Spain, 30203
    Status
    Study Complete
    Location
    GSK Investigational Site
    Weinheim, Baden-Wuerttemberg, Germany, 69469
    Status
    Study Complete
    Location
    GSK Investigational Site
    Deggingen, Baden-Wuerttemberg, Germany, 73326
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lake Charles, Louisiana, United States, 70601
    Status
    Study Complete
    Location
    GSK Investigational Site
    Euskirchen, Nordrhein-Westfalen, Germany, 53879
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zaragoza, Spain, 50003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Usti Nad Labem, Czech Republic, 401 13
    Status
    Study Complete
    Location
    GSK Investigational Site
    Regina, Saskatchewan, Canada, S4P 0W5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Boulder, Colorado, United States, 80304
    Status
    Study Complete
    Location
    GSK Investigational Site
    Doncaster, United Kingdom, DN1 2EG
    Status
    Study Complete
    Location
    GSK Investigational Site
    Belfast, Ireland, BT16 ORH
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charleston, West Virginia, United States, 25304
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fort Myers, Florida, United States, 33907
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rijswijk, Netherlands, 2281 AK
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hemel Hempstead, Hertfordshire, United Kingdom, HP2 4AD
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    West Chester, Pennsylvania, United States, 19380
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Louis, Missouri, United States, 63110
    Status
    Study Complete
    Location
    GSK Investigational Site
    Udine, Italy, 33100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Detroit, Michigan, United States, 48201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Losser, Netherlands, 7582 BD
    Status
    Study Complete
    Location
    GSK Investigational Site
    Freital, Sachsen, Germany, 01705
    Status
    Study Complete
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68131
    Status
    Study Complete
    Location
    GSK Investigational Site
    Boechout, Belgium, 2530
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10021
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21205
    Status
    Study Complete
    Location
    GSK Investigational Site
    Irving, Texas, United States, 75061
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L5M 2N1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Offenbach, Hessen, Germany, 63073
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ottawa, Ontario, Canada, K1H 7W9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muenchen, Bayern, Germany, 80339
    Status
    Study Complete
    Location
    GSK Investigational Site
    Figueras, Spain, 17600
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aschaffenburg, Bayern, Germany, 63739
    Status
    Study Complete
    Location
    GSK Investigational Site
    Phaha 5, Czech Republic, 150 06
    Status
    Study Complete
    Location
    GSK Investigational Site
    St Pierre de Chandieu, France, 69780
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wijnegem, Belgium, 2110
    Status
    Study Complete
    Location
    GSK Investigational Site
    Warendorf, Nordrhein-Westfalen, Germany, 48231
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99207
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bad Rappenau, Baden-Wuerttemberg, Germany, 74906
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muenchen, Bayern, Germany, 81379
    Status
    Recruiting
    Location
    GSK Investigational Site
    Jackson, Mississippi, United States, 39202
    Status
    Study Complete
    Location
    GSK Investigational Site
    Slidell, Louisiana, United States, 70461
    Status
    Study Complete
    Location
    GSK Investigational Site
    Haag, Bayern, Germany, 83527
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint John's, Newfoundland and Labrador, Canada, A1B 3V6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Elda-Alicante, Spain, 03600
    Status
    Study Complete
    Location
    GSK Investigational Site
    Flushing, New York, United States, 11365
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wilster, Schleswig-Holstein, Germany, 25554
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nashville, Tennessee, United States, 37211
    Status
    Study Complete
    Location
    GSK Investigational Site
    Albuquerque, New Mexico, United States, 87102
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montignac, France, 24290
    Status
    Study Complete
    Location
    GSK Investigational Site
    Laval, Québec, Canada, H7T 2P5
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wigan, United Kingdom, WN1 1XX
    Status
    Study Complete
    Location
    GSK Investigational Site
    Denver, Colorado, United States, 80209
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greer, South Carolina, United States, 29651
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, United Kingdom, W1M 7AB
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muenchen, Bayern, Germany, 80469
    Status
    Study Complete
    Location
    GSK Investigational Site
    Madrid, Spain, 28006
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 13057
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, Ontario, Canada, N6A 4V2
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78229
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charlottesville, Virginia, United States, 22908
    Status
    Study Complete
    Location
    GSK Investigational Site
    Thornhill, Ontario, Canada, L4J 1V8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kuenzing, Bayern, Germany, 94550
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Giovanni Rotondo FG, Italy
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nantes, France, 44300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pittsburgh, Pennsylvania, United States, 15219
    Status
    Study Complete
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35233
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barnsley, United Kingdom, S70 3RJ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gurnee, Illinois, United States, 60031
    Status
    Study Complete
    Location
    GSK Investigational Site
    Palermo, Italy, 90127
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hildesheim, Niedersachsen, Germany, 31139
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dublin, Ireland, 8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Albaida (Valencia), Spain
    Status
    Study Complete
    Location
    GSK Investigational Site
    Reading, Berkshire, United Kingdom, RG2 7AG
    Status
    Recruiting
    Location
    GSK Investigational Site
    Sandy, Bedfordshire, United Kingdom, SG19 3JR
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gerona, Spain
    Status
    Study Complete
    Location
    GSK Investigational Site
    St Genies Des Fontaines, France, 66740
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30338
    Status
    Study Complete
    Location
    GSK Investigational Site
    Paradis, Norway, 5231
    Status
    Study Complete
    Location
    GSK Investigational Site
    St-Isidore de Dorchester, Québec, Canada, G0S 2S0
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bronx, New York, United States, 10461
    Status
    Study Complete
    Location
    GSK Investigational Site
    Le Pian Medoc, France, 33290
    Status
    Study Complete
    Location
    GSK Investigational Site
    Titusville, Florida, United States, 32796
    Status
    Study Complete
    Location
    GSK Investigational Site
    Modesto, California, United States, 95355
    Status
    Study Complete
    Location
    GSK Investigational Site
    Glasgow, Lanarkshire, United Kingdom, G81 4SA
    Status
    Study Complete
    Location
    GSK Investigational Site
    Windsor, Ontario, Canada, N8X 1K4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Goch, Nordrhein-Westfalen, Germany, 47574
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wahlstedt, Schleswig-Holstein, Germany, 23812
    Status
    Study Complete
    Location
    GSK Investigational Site
    Budapest, Hungary, 1076
    Status
    Study Complete
    Location
    GSK Investigational Site
    Syracuse, New York, United States, 13210
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dortmund, Nordrhein-Westfalen, Germany, 44137
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bath, United Kingdom, BA2 3HT
    Status
    Study Complete
    Location
    GSK Investigational Site
    Valencia, Spain, 46830
    Status
    Study Complete
    Location
    GSK Investigational Site
    Helsinki, Finland, 00150
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salt Lake City, Utah, United States, 84103
    Status
    Study Complete
    Location
    GSK Investigational Site
    Duisburg, Nordrhein-Westfalen, Germany, 47119
    Status
    Study Complete
    Location
    GSK Investigational Site
    Terni, Italy, 05100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Denver, Colorado, United States, 80220
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Etienne, France, 42000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Longmont, Colorado, United States, 80501
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oakville, Ontario, Canada, L6H 3P1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Strasbourg, France, 67000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Catania, Sicilia, Italy, 95100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Antigonish, Nova Scotia, Canada, B2G 2C2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Indianapolis, Indiana, United States, 46202
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nuernberg, Bayern, Germany, 90427
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fresno, California, United States, 93720
    Status
    Study Complete
    Location
    GSK Investigational Site
    Krummenaab, Bayern, Germany, 92703
    Status
    Study Complete
    Location
    GSK Investigational Site
    Diez, Rheinland-Pfalz, Germany, 65582
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chicoutimi, Québec, Canada, G7H 5H6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moulon, France, 33420
    Status
    Study Complete
    Location
    GSK Investigational Site
    Henderson, Nevada, United States, 89014
    Status
    Study Complete
    Location
    GSK Investigational Site
    Den Bosch, Netherlands, 5223 GV
    Status
    Study Complete
    Location
    GSK Investigational Site
    Boise, Idaho, United States, 83706
    Status
    Study Complete
    Location
    GSK Investigational Site
    Valencia, Spain
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sagunto/Valencia, Spain, 46520
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lille, France, 59000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Downington, Pennsylvania, United States, 19335
    Status
    Study Complete
    Location
    GSK Investigational Site
    Haverfordwest, Pembrokeshire, United Kingdom, SA61 1RN
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vallda (Valencia), Spain
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77030
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Juan (Alicante), Spain, 03550
    Status
    Study Complete
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19115
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mesa, Arizona, United States, 85206
    Status
    Study Complete
    Location
    GSK Investigational Site
    Losser, Netherlands, 7581 BV
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wezembeek-Oppem, Belgium, 1970
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tenerife, Spain, 38010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hannover, Niedersachsen, Germany, 30171
    Status
    Study Complete
    Location
    GSK Investigational Site
    Springfield, Illinois, United States, 62704
    Status
    Study Complete
    Location
    GSK Investigational Site
    Schwabenheim, Nordrhein-Westfalen, Germany, 55270
    Status
    Study Complete
    Location
    GSK Investigational Site
    La Rochelle, France, 17000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30312
    Status
    Study Complete
    Location
    GSK Investigational Site
    Stevenage, Hertfordshire, United Kingdom
    Status
    Study Complete
    Location
    GSK Investigational Site
    Albuquerque, New Mexico, United States, 87106
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edinburgh, Midlothian, United Kingdom, EH3 9YW
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vourey, France, 38210
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cork, Ireland
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H1T 2M4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H2W 1T8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Landshut, Bayern, Germany, 84028
    Status
    Study Complete
    Location
    GSK Investigational Site
    Midland, Texas, United States, 79705
    Status
    Study Complete
    Location
    GSK Investigational Site
    Villajoyosa - Alicante, Spain, 03570
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sta Coloma de Gramanet (Barcelona), Spain, 08923
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tielt, Belgium, 8700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Llanelli, Carmarthenshire, United Kingdom, SA14 8QF
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cardiff, Glamorgan, United Kingdom, CF14 9BB
    Status
    Study Complete
    Location
    GSK Investigational Site
    Milano, Italy, 20132
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chicago, Illinois, United States, 60612
    Status
    Study Complete
    Location
    GSK Investigational Site
    St Julien Des Landes, France, 85150
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lubbeek (Linden), Belgium, B-3210
    Status
    Study Complete
    Location
    GSK Investigational Site
    Degerberga, Sweden, 297 31
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bradford, United Kingdom, BD7 3EE
    Status
    Study Complete
    Location
    GSK Investigational Site
    La Jolla, California, United States, 92037
    Status
    Study Complete
    Location
    GSK Investigational Site
    Newport News, Virginia, United States, 23606
    Status
    Study Complete
    Location
    GSK Investigational Site
    Woerden, Netherlands, 3443 GG
    Status
    Study Complete
    Location
    GSK Investigational Site
    Burlington, Ontario, Canada, L7M 4Y1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Elche (Alicante), Spain, 03202
    Status
    Study Complete
    Location
    GSK Investigational Site
    Trowbridge, Wiltshire, United Kingdom, BA14 8TG
    Status
    Study Complete
    Location
    GSK Investigational Site
    Valencia, Spain, 46017
    Status
    Study Complete
    Location
    GSK Investigational Site
    MALMÖ, Sweden, SE-214 26
    Status
    Study Complete
    Location
    GSK Investigational Site
    Honolulu, Hawaii, United States, 96813
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dublin, Ireland, 4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hermitage, Pennsylvania, United States, 16148
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Beckum, Nordrhein-Westfalen, Germany, 59269
    Status
    Study Complete
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68105
    Status
    Study Complete
    Location
    GSK Investigational Site
    Peterborough, United Kingdom, PE7 3JL
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hamar, Norway, 2317
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ravenna, Emilia-Romagna, Italy, 48100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ismaning, Bayern, Germany, 85737
    Status
    Study Complete
    Location
    GSK Investigational Site
    Frankfurt, Hessen, Germany, 60326
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92126
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78207
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77024
    Status
    Study Complete
    Location
    GSK Investigational Site
    Victoria, British Columbia, Canada, V8R 6T9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bristol, Tennessee, United States, 37620
    Status
    Study Complete
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19148
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rochester, New York, United States, 14609
    Status
    Study Complete
    Location
    GSK Investigational Site
    Washington, District of Columbia, United States, 20037
    Status
    Study Complete
    Location
    GSK Investigational Site
    London, United Kingdom, SE1 9RT
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kilkenny, Ireland
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charlottetown, Prince Edward Island, Canada, C1A 1L2
    Status
    Study Complete
    Location
    GSK Investigational Site
    Barry, Glamorgan, United Kingdom, CF63 4HP
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hollywood, Florida, United States, 33023
    Status
    Study Complete
    Location
    GSK Investigational Site
    Portland, Oregon, United States, 97239
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10032
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75390
    Status
    Study Complete
    Location
    GSK Investigational Site
    Glenrothes, United Kingdom
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lexington, Kentucky, United States, 40504-2681
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plessisville, Québec, Canada, G6L 3J1
    Status
    Study Complete
    Location
    GSK Investigational Site
    Acquaviva delle Fonti (BA), Puglia, Italy, 70021
    Status
    Study Complete
    Location
    GSK Investigational Site
    Coquitlam, British Columbia, Canada, V3K 3P4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Città di Castello (PG), Umbria, Italy, 06012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Westlake, Ohio, United States, 44145
    Status
    Study Complete
    Location
    GSK Investigational Site
    Winnipeg, Manitoba, Canada, R2H 2A6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rovigo, Italy, 45100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Deidesheim, Rheinland-Pfalz, Germany, 67146
    Status
    Study Complete
    Location
    GSK Investigational Site
    Loma Linda, California, United States, 92354
    Status
    Study Complete
    Location
    GSK Investigational Site
    Albuquerque, New Mexico, United States, 87109
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spartanburg, South Carolina, United States, 29303
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zamora, Spain, 49021
    Status
    Study Complete
    Location
    GSK Investigational Site
    Madison, Wisconsin, United States, 53717
    Status
    Study Complete
    Location
    GSK Investigational Site
    Marsillargues, France, 34590
    Status
    Study Complete
    Location
    GSK Investigational Site
    Alben, France, 73410
    Status
    Study Complete
    Location
    GSK Investigational Site
    Berkeley, California, United States, 94705
    Status
    Study Complete
    Location
    GSK Investigational Site
    HUIZEN, Netherlands, 1271 BB
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dresden, Sachsen, Germany, 01309
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30308
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Petersburg, Florida, United States, 33702
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nuneaton, Warwickshire, United Kingdom, CV10 7DJ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sudbury, Ontario, Canada, P3A 1Y8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21204
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jerez (Cadiz), Spain, 11047
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jacksonville, Florida, United States, 32204
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rochester, New York, United States, 14642
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rugby, Warwickshire, United Kingdom, CV21 3SP
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dresden, Sachsen, Germany, 01187
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wiener Neustadt, Austria, A-2700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ann Arbor, Michigan, United States, 48109
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nimes, France, 30900
    Status
    Study Complete
    Location
    GSK Investigational Site
    West Palm Beach, Florida, United States, 33401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vicenza, Italy, 36100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tucson, Arizona, United States, 85723
    Status
    Study Complete
    Location
    GSK Investigational Site
    Englewood, Colorado, United States, 80110
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fremont, California, United States, 94538
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muenchen, Bayern, Germany, 80807
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jyvaskyla, Finland, 40100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Olleria, Valencia, Spain, 46850
    Status
    Study Complete
    Location
    GSK Investigational Site
    Poole, Dorset, United Kingdom
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30322
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oregon, Wisconsin, United States, 53575
    Status
    Study Complete
    Location
    GSK Investigational Site
    Corona, California, United States, 92879
    Status
    Study Complete
    Location
    GSK Investigational Site
    Muenchen, Bayern, Germany, 80805
    Status
    Study Complete
    Location
    GSK Investigational Site
    Blankenberge, Belgium, 8370
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dresden, Sachsen, Germany, 01129
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huntington, West Virginia, United States, 25701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Billings, Montana, United States, 59102
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gimo, Sweden, SE-747 43
    Status
    Study Complete
    Location
    GSK Investigational Site
    Albany, New York, United States, 12206
    Status
    Study Complete
    Location
    GSK Investigational Site
    Corpus Christi, Texas, United States, 78411
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dublin, Ireland, 7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Thunder Bay, Ontario, Canada, P7B 2Z3
    Status
    Study Complete
    Location
    GSK Investigational Site
    Doncaster, United Kingdom, DN9 1EP
    Status
    Study Complete
    Location
    GSK Investigational Site
    Boston, Massachusetts, United States, 02114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kansas City, Missouri, United States, 64132
    Status
    Study Complete
    Location
    GSK Investigational Site
    Deurne, Belgium, 2100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sunnyvale, California, United States, 94086
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fayetteville, Georgia, United States, 30214
    Status
    Study Complete
    Location
    GSK Investigational Site
    Paris, France, 75015
    Status
    Study Complete
    Location
    GSK Investigational Site
    Schmiedeberg, Sachsen, Germany, 01762
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Petersburg, Florida, United States, 33710
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cherry Hill, New Jersey, United States, 08034
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plasencia, Spain, 10600
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bergkamen, Nordrhein-Westfalen, Germany, 59192
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sassari, Italy
    Status
    Study Complete
    Location
    GSK Investigational Site
    Olive Branch, Mississippi, United States, 38654
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nottingham, Nottinghamshire, United Kingdom, NG3 7DQ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sisteron, France, 04200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Torino, Italy, 10126
    Status
    Study Complete
    Location
    GSK Investigational Site
    Co. Tipperary, Ireland
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nantes Cedex 01, France, 44093
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Salem, Virginia, United States, 24153
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hannover, Niedersachsen, Germany, 30177
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fort Worth, Texas, United States, 76107
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vienna, Austria, A-1080
    Status
    Study Complete
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19104
    Status
    Study Complete
    Location
    GSK Investigational Site
    Blue Ridge, Georgia, United States, 30513
    Status
    Study Complete
    Location
    GSK Investigational Site
    Springfield, Massachusetts, United States, 01199
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rennes, France, 35200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bad Kreuznach, Hessen, Germany, 55545
    Status
    Study Complete
    Location
    GSK Investigational Site
    Slidell, Louisiana, United States, 70458
    Status
    Study Complete
    Location
    GSK Investigational Site
    Calgary, Alberta, Canada, T2R 0X7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Healdsburg, California, United States, 95448
    Status
    Study Complete
    Location
    GSK Investigational Site
    De Bilt, Netherlands, 3731 DN
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fair Oaks, California, United States, 95628
    Status
    Study Complete
    Location
    GSK Investigational Site
    Irvine, United Kingdom, KA12 OAY
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hoehenkirchen-Siegertsbrunn, Bayern, Germany, 85635
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bend, Oregon, United States, 97701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Granollers (Barcelona), Spain, 08400
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gowran, Ireland
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chemnitz, Sachsen, Germany, 09130
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wakefield, United Kingdom, WF1 4DG
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wheat Ridge, Colorado, United States, 80033
    Status
    Study Complete
    Location
    GSK Investigational Site
    Grossalmerode, Hessen, Germany, 37247
    Status
    Study Complete
    Location
    GSK Investigational Site
    Damme, Niedersachsen, Germany, 49401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Le Mans, France, 72000
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Louis, Missouri, United States, 63128
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gamarde Les Bains, France, 40380
    Status
    Study Complete
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90095
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rozzano (MI), Lombardia, Italy, 20089
    Status
    Study Complete
    Location
    GSK Investigational Site
    Odense, Denmark, 5000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Co.Antrim, United Kingdom
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oklahoma City, Oklahoma, United States, 73104
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saint Marc Des Carrieres, Québec, Canada, G0A 4B0
    Status
    Study Complete
    Location
    GSK Investigational Site
    Endwell, New York, United States, 13760
    Status
    Study Complete
    Location
    GSK Investigational Site
    Firenze, Italy, 50134
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wenatchee, Washington, United States, 98801
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salt Lake City, Utah, United States, 84108
    Status
    Study Complete
    Location
    GSK Investigational Site
    Charleston, South Carolina, United States, 29403
    Status
    Study Complete
    Location
    GSK Investigational Site
    Indianapolis, Indiana, United States, 46250
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zemst, Belgium, 1980
    Status
    Study Complete
    Location
    GSK Investigational Site
    Minneapolis, Minnesota, United States, 55407-3799
    Status
    Study Complete
    Location
    GSK Investigational Site
    Madrid, Spain, 28046
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bangor, Maine, United States, 04401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Itzehoe, Schleswig-Holstein, Germany, 25524
    Status
    Study Complete
    Location
    GSK Investigational Site
    Valladolid, Spain, 47010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vieux Conde, France, 59690
    Status
    Study Complete
    Location
    GSK Investigational Site
    Basurto/Bilbao, Spain, 48013
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Tampa, Florida, United States, 33612
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lansing, Michigan, United States, 48912
    Status
    Study Complete
    Location
    GSK Investigational Site
    Schaafheim, Hessen, Germany, 64850
    Status
    Study Complete
    Location
    GSK Investigational Site
    El Palmar (Murcia), Spain, 30120
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cherry Hill, New Jersey, United States, 8034
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richmond, Virginia, United States, 23249
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lueneburg, Niedersachsen, Germany, 21335
    Status
    Study Complete
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T5N 3Y6
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orthez, France, 64300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Federal Way, Washington, United States, 98003
    Status
    Study Complete
    Location
    GSK Investigational Site
    S. Benedetto TR (AP), Italy
    Status
    Study Complete
    Location
    GSK Investigational Site
    Portland, Oregon, United States, 97219
    Status
    Study Complete
    Location
    GSK Investigational Site
    Savitaipale, Finland, 54800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Red Deer, Alberta, Canada, T4N 6V7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tarare, France, 69170
    Status
    Study Complete
    Location
    GSK Investigational Site
    Luedenscheid, Nordrhein-Westfalen, Germany, 58511
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sherbrooke, Québec, Canada, J1H 5N4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ostrava, Czech Republic, 703 52
    Status
    Study Complete
    Location
    GSK Investigational Site
    Santa Rosa, California, United States, 95405
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tereul, Spain, 44002
    Status
    Study Complete
    Location
    GSK Investigational Site
    Marssac, France, 81150
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zlin, Czech Republic, 762 75
    Status
    Study Complete
    Location
    GSK Investigational Site
    Neuss, Nordrhein-Westfalen, Germany, 41460
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hanko, Finland, 10900
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chartres, France, 28000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dublin, Ireland, 24
    Status
    Study Complete
    Location
    GSK Investigational Site
    Melksham, Wiltshire, United Kingdom, SN12 6UN
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21208
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gateshead, United Kingdom, NE9 6SX
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pasadena, California, United States, 91105
    Status
    Study Complete
    Location
    GSK Investigational Site
    Arlington, Texas, United States, 76014
    Status
    Study Complete
    Location
    GSK Investigational Site
    Minneapolis, Minnesota, United States, 55404
    Status
    Study Complete
    Location
    GSK Investigational Site
    Trochtelfingen, Baden-Wuerttemberg, Germany, 72818
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33136
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vellmar, Hessen, Germany, 34246
    Status
    Study Complete
    Location
    GSK Investigational Site
    Washington, District of Columbia, United States, 20003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Toledo, Spain, 45004
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lollar, Hessen, Germany, 35475
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jefferson Hills, Pennsylvania, United States, 15025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jacksonville, Florida, United States, 32216
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cleveland, Ohio, United States, 44121
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30328
    Status
    Study Complete
    Location
    GSK Investigational Site
    Newtownabbey, United Kingdom, BT36 4PP
    Status
    Study Complete
    Location
    GSK Investigational Site
    Offenbach, Hessen, Germany, 63071
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99204
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orlando, Florida, United States, 32806
    Status
    Study Complete
    Location
    GSK Investigational Site
    Livingston, West Lothian, United Kingdom, EH54 6PP
    Status
    Study Complete
    Location
    GSK Investigational Site
    lmatra, Finland, 55800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Palm Harbor, Florida, United States, 34683
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kingston, Ontario, Canada, K7L 2V7
    Status
    Study Complete
    Location
    GSK Investigational Site
    Labarthe Sur Leze, France, 31860
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Vincente Raspeig (Alicante), Spain, 03690
    Status
    Study Complete
    Location
    GSK Investigational Site
    Skedsmokorset, Norway, N-2020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Parma, Italy, 43100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Praha 4, Czech Republic, 142 00
    Status
    Study Complete
    Location
    GSK Investigational Site
    Benicasim (Castellón), Spain
    Status
    Study Complete
    Location
    GSK Investigational Site
    Offenbach, Hessen, Germany, 63065
    Status
    Study Complete
    Location
    GSK Investigational Site
    Roanna, France, 42300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cardiff, United Kingdom, CF5 4AE
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wallerfing, Bayern, Germany, 94574
    Status
    Study Complete
    Location
    GSK Investigational Site
    Eugene, Oregon, United States, 97401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Evansville, Indiana, United States, 47713
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orihuela (Alicante), Spain, 03314
    Status
    Study Complete
    Location
    GSK Investigational Site
    Walnut Creek, California, United States, 94598
    Status
    Study Complete
    Location
    GSK Investigational Site
    Paderborn, Niedersachsen, Germany, 33100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fullerton, California, United States, 92835
    Status
    Study Complete
    Location
    GSK Investigational Site
    Milwaukee, Wisconsin, United States, 53209
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Perugia, Italy, 06126
    Status
    Study Complete
    Location
    GSK Investigational Site
    Murs Erigne, France, 49610
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33176
    Status
    Study Complete
    Location
    GSK Investigational Site
    La Malbaie, Québec, Canada, G5A 1W7
    Status
    Study Complete
    Location
    GSK Investigational Site
    New York, New York, United States, 10029
    Status
    Study Complete
    Location
    GSK Investigational Site
    Winnipeg, Manitoba, Canada, R3E 3P4
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miskolc, Hungary, 3526
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mallemort, France, 13370
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ukiah, California, United States, 95482
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wellingborough, Northamptonshire, United Kingdom, NN8 4RW
    Status
    Study Complete
    Location
    GSK Investigational Site
    Torrelavega/Santander, Spain, 39300
    Status
    Study Complete
    Location
    GSK Investigational Site
    Saskatoon, Saskatchewan, Canada, S7N 0W8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbia, South Carolina, United States, 29201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hamburg, Hamburg, Germany, 22607
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bezier, France, 34500
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bournemouth, Dorset, United Kingdom, BH7 7DW
    Status
    Study Complete
    Location
    GSK Investigational Site
    New Orleans, Louisiana, United States, 70119
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pirna, Sachsen, Germany, 01796
    Status
    Study Complete
    Location
    GSK Investigational Site
    Luenen, Nordrhein-Westfalen, Germany, 44534
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75231
    Status
    Study Complete
    Location
    GSK Investigational Site
    Warminster, Pennsylvania, United States, 18974
    Status
    Study Complete
    Location
    GSK Investigational Site
    Airdrie, Lanarkshire, United Kingdom, ML6 0JS
    Status
    Study Complete
    Location
    GSK Investigational Site
    Moncton, New Brunswick, Canada, E1C 6Z8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Winsen/Lohe, Niedersachsen, Germany, 21423
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lecce, Italy, 73100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Aberdeen, Aberdeenshire, United Kingdom, AB25 2AY
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bourges, France, 18000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19107
    Status
    Study Complete
    Location
    GSK Investigational Site
    Warrington, Cheshire, United Kingdom, WA5 1QC
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wheat Ridge, Colorado, United States, 80043
    Status
    Study Complete
    Location
    GSK Investigational Site
    Duhwoody, Georgia, United States, 30338
    Status
    Study Complete
    Location
    GSK Investigational Site
    Swansea, United Kingdom, SA4 4BY
    Status
    Study Complete
    Location
    GSK Investigational Site
    Borken, Nordrhein-Westfalen, Germany, 46325
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mogadore, Ohio, United States, 44260
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cambellton, New Brunswick, Canada, E3N 3S8
    Status
    Study Complete
    Location
    GSK Investigational Site
    Onda/Castellón, Spain, 12200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Scandiano (RE), Emilia-Romagna, Italy, 42019
    Status
    Study Complete
    Location
    GSK Investigational Site
    Offenbach, Hessen, Germany, 63067
    Status
    Study Complete
    Location
    GSK Investigational Site
    Wangen, Baden-Wuerttemberg, Germany, 88239
    Status
    Study Complete
    Location
    GSK Investigational Site
    Harbor City, California, United States, 90710
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sarasota, Florida, United States, 34239
    Status
    Study Complete
    Location
    GSK Investigational Site
    Frederiksberg C, Denmark, 1900
    Status
    Study Complete
    Location
    GSK Investigational Site
    Seattle, Washington, United States, 98195
    Status
    Study Complete
    Location
    GSK Investigational Site
    Frome, Somerset, United Kingdom, BA11 1EZ
    Status
    Study Complete
    Location
    GSK Investigational Site
    Seattle, Washington, United States, 98104
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mannheim, Baden-Wuerttemberg, Germany, 68161
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cincinnati, Ohio, United States, 45219
    Status
    Study Complete
    Location
    GSK Investigational Site
    Little Rock, Arkansas, United States, 77205
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bolton, Lancashire, United Kingdom
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mont de Marsen, France, 40000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bilbao, Spain, 48013
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cleveland, Ohio, United States, 44195
    Status
    Study Complete
    Location
    GSK Investigational Site
    Benassal (Castellón), Spain, 12160
    Status
    Study Complete
    Location
    GSK Investigational Site
    Durham, North Carolina, United States, 27710
    Status
    Study Complete
    Location
    GSK Investigational Site
    Leicester, United Kingdom, LE3 8GS
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ratzeburg, Schleswig-Holstein, Germany, 23909
    Status
    Study Complete
    Location
    GSK Investigational Site
    Alta, Sweden, 138 21
    Status
    Study Complete
    Location
    GSK Investigational Site
    STOCKHOLM, Sweden, SE-114 35
    Status
    Study Complete
    Location
    GSK Investigational Site
    Essen, Nordrhein-Westfalen, Germany, 45130
    Status
    Study Complete
    Location
    GSK Investigational Site
    Minneapolis, Minnesota, United States, 55416
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chorley, Lancashire, United Kingdom, PR7 1NY
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cáceres, Spain, 10005
    Status
    Study Complete
    Location
    GSK Investigational Site
    Denguin, France, 64230
    Status
    Study Complete
    Location
    GSK Investigational Site
    Glasgow, United Kingdom, G51 4TF
    Status
    Study Complete
    Location
    GSK Investigational Site
    Yorba Linda, California, United States, 92886
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rhaunen, Rheinland-Pfalz, Germany, 55624
    Status
    Study Complete
    Location
    GSK Investigational Site
    Vancouver, British Columbia, Canada, V5Z 1M9
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hershey, Pennsylvania, United States, 17033
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ferrara, Emilia-Romagna, Italy, 44100
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hamburg, Hamburg, Germany, 22041
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dublin, Ireland, 15
    Status
    Study Complete
    Location
    GSK Investigational Site
    Unterschneidheim, Baden-Wuerttemberg, Germany, 73485
    Status
    Study Complete
    Location
    GSK Investigational Site
    Brogile, France, 27270
    Status
    Study Complete
    Location
    GSK Investigational Site
    Merida, Spain, 6800
    Status
    Study Complete
    Location
    GSK Investigational Site
    Beaumont, Texas, United States, 77701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Siegen, Nordrhein-Westfalen, Germany, 57072
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greenbrae, California, United States, 94904
    Status
    Study Complete
    Location
    GSK Investigational Site
    Marseille, France, 13001
    Status
    Study Complete
    Location
    GSK Investigational Site
    La Spezia, Italy, 19100
    Status
    Study Complete
    Location
    GSK Investigational Site
    MARSEILLE, France, 13008
    Status
    Study Complete
    Location
    GSK Investigational Site
    Halifax, Nova Scotia, Canada, B3H 1V7
    Status
    Study Complete

    Study documents

    Clinical study report
    Available language(s): English
    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    2006-19-06

    Plain language summaries

    Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

    Additional information about the trial

    Participate in clinical trial
    Additional information
    Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
    Click here
    Access to clinical trial data by researchers
    Visit website